{
    "id": 3388,
    "fullName": "KIT Y570_L576del",
    "impact": "deletion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "KIT Y570_L576del results in the deletion of seven amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 570 to 576 (PMID: 16226710). Y570_L576del has not been characterized, however similar Kit exon 11 deletions are activating, thus Y570_L576del is predicted to lead to a gain of Kit protein function (PMID: 9438854, PMID: 15365079).",
            "references": [
                {
                    "id": 648,
                    "pubMedId": 16226710,
                    "title": "Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16226710"
                },
                {
                    "id": 2054,
                    "pubMedId": 15365079,
                    "title": "Biology of gastrointestinal stromal tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15365079"
                },
                {
                    "id": 650,
                    "pubMedId": 9438854,
                    "title": "Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9438854"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3815,
        "geneSymbol": "KIT",
        "terms": [
            "KIT",
            "C-Kit",
            "CD117",
            "MASTC",
            "PBT",
            "SCFR"
        ]
    },
    "variant": "Y570_L576del",
    "createDate": "02/26/2015",
    "updateDate": "05/14/2019",
    "referenceTranscriptCoordinates": {
        "id": 137012,
        "transcript": "NM_000222",
        "gDna": "chr4:g.54727476_54727496del21",
        "cDna": "c.1708_1728del21",
        "protein": "p.Y570_L576delYIDPTQL",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14372,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sutent (sunitinib) demonstrated limited inhibition of Kit, Erk, and Mtor signaling and resulted in minimal (22.9%) tumor inhibition in patient-derived xenograft (PDX) model of gastrointestinal stromal tumor harboring KIT D816E, KIT Y570_L576del, and PTEN T321fs, which was established from a patient who did not respond to Gleevec (imatinib mesylate), Sutent (sunitinib), and Nexavar (sorafenib) (PMID: 29100343).",
            "molecularProfile": {
                "id": 29990,
                "profileName": "KIT Y570_L576del KIT D816E PTEN T321fs"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 9253,
                "name": "gastrointestinal stromal tumor",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 11624,
                    "pubMedId": 29100343,
                    "title": "Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29100343"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 14382,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib mesylate) in combination with LY394002 resulted in enhanced tumor growth inhibition compared to monotherapy in patient-derived xenograft (PDX) model of gastrointestinal stromal tumor harboring KIT D816E, KIT Y570_L576del, and PTEN T321fs, which was established from a patient who did not respond to Gleevec (imatinib mesylate), Sutent (sunitinib), and Nexavar (sorafenib) (PMID: 29100343).",
            "molecularProfile": {
                "id": 29990,
                "profileName": "KIT Y570_L576del KIT D816E PTEN T321fs"
            },
            "therapy": {
                "id": 7087,
                "therapyName": "Imatinib + LY294002",
                "synonyms": null
            },
            "indication": {
                "id": 9253,
                "name": "gastrointestinal stromal tumor",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 11624,
                    "pubMedId": 29100343,
                    "title": "Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29100343"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 14373,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Stivarga (regorafenib) inhibited Kit, Erk, and Mtor signaling, resulted in tumor growth inhibition in patient-derived xenograft (PDX) model of gastrointestinal stromal tumor harboring KIT D816E, KIT Y570_L576del, and PTEN T321fs, which was established from a patient who did not respond to Gleevec (imatinib mesylate), Sutent (sunitinib), and Nexavar (sorafenib) (PMID: 29100343).",
            "molecularProfile": {
                "id": 29990,
                "profileName": "KIT Y570_L576del KIT D816E PTEN T321fs"
            },
            "therapy": {
                "id": 890,
                "therapyName": "Regorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 9253,
                "name": "gastrointestinal stromal tumor",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 11624,
                    "pubMedId": 29100343,
                    "title": "Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29100343"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 14371,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib mesylate) did not inhibit Kit, Erk, or Mtor signaling and resulted in minimal tumor inhibition in patient-derived xenograft (PDX) model of gastrointestinal stromal tumor harboring KIT D816E, KIT Y570_L576del, and PTEN T321fs, which was established from a patient who did not respond to Gleevec (imatinib mesylate), Sutent (sunitinib), and Nexavar (sorafenib) (PMID: 29100343).",
            "molecularProfile": {
                "id": 29990,
                "profileName": "KIT Y570_L576del KIT D816E PTEN T321fs"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 9253,
                "name": "gastrointestinal stromal tumor",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 11624,
                    "pubMedId": 29100343,
                    "title": "Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29100343"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3197,
            "profileName": "KIT Y570_L576del",
            "profileTreatmentApproaches": [
                {
                    "id": 7710,
                    "name": "KIT Inhibitor",
                    "profileName": "KIT Y570_L576del"
                }
            ]
        },
        {
            "id": 29990,
            "profileName": "KIT Y570_L576del KIT D816E PTEN T321fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 137012,
            "transcript": "NM_000222",
            "gDna": "chr4:g.54727476_54727496del21",
            "cDna": "c.1708_1728del21",
            "protein": "p.Y570_L576delYIDPTQL",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 137016,
            "transcript": "XM_017008179",
            "gDna": "chr4:g.54727486_54727506del21",
            "cDna": "c.1709_1729del21",
            "protein": "p.P570_D576delPTQLPYD",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 137015,
            "transcript": "XM_005265741",
            "gDna": "chr4:g.54727473_54727493del21",
            "cDna": "c.1708_1728del21",
            "protein": "p.V570_Q576delVYIDPTQ",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 137017,
            "transcript": "XM_017008178",
            "gDna": "chr4:g.54727476_54727496del21",
            "cDna": "c.1708_1728del21",
            "protein": "p.Y570_L576delYIDPTQL",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 137018,
            "transcript": "XM_017008180",
            "gDna": "chr4:g.54727489_54727509del21",
            "cDna": "c.1709_1729del21",
            "protein": "p.T570_H576delTQLPYDH",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 137014,
            "transcript": "XM_005265740",
            "gDna": "chr4:g.54727473_54727493del21",
            "cDna": "c.1708_1728del21",
            "protein": "p.V570_Q576delVYIDPTQ",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 137019,
            "transcript": "XM_005265742",
            "gDna": "chr4:g.54727486_54727506del21",
            "cDna": "c.1709_1729del21",
            "protein": "p.P570_D576delPTQLPYD",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 137013,
            "transcript": "NM_001093772",
            "gDna": "chr4:g.54727489_54727509del21",
            "cDna": "c.1709_1729del21",
            "protein": "p.T570_H576delTQLPYDH",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}